nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—kidney cancer	0.384	1	CiPCiCtD
Gemcitabine—urinary bladder cancer—kidney cancer	0.112	0.395	CtDrD
Gemcitabine—pancreatic cancer—kidney cancer	0.0946	0.335	CtDrD
Gemcitabine—CDA—Capecitabine—kidney cancer	0.0819	0.444	CbGbCtD
Gemcitabine—lung cancer—kidney cancer	0.0764	0.27	CtDrD
Gemcitabine—ABCB1—kidney cancer	0.0371	1	CbGaD
Gemcitabine—TYMS—Capecitabine—kidney cancer	0.0365	0.198	CbGbCtD
Gemcitabine—ABCC10—Paclitaxel—kidney cancer	0.0188	0.102	CbGbCtD
Gemcitabine—ABCC10—Vincristine—kidney cancer	0.0162	0.0881	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—kidney cancer	0.0102	0.0551	CbGbCtD
Gemcitabine—ABCB1—Temsirolimus—kidney cancer	0.00511	0.0277	CbGbCtD
Gemcitabine—ABCB1—Pazopanib—kidney cancer	0.00269	0.0146	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—kidney cancer	0.00246	0.0133	CbGbCtD
Gemcitabine—ABCB1—Erlotinib—kidney cancer	0.00192	0.0104	CbGbCtD
Gemcitabine—ABCB1—Paclitaxel—kidney cancer	0.00175	0.00952	CbGbCtD
Gemcitabine—ABCB1—Sorafenib—kidney cancer	0.00156	0.00845	CbGbCtD
Gemcitabine—ABCB1—Vinblastine—kidney cancer	0.00154	0.00835	CbGbCtD
Gemcitabine—ABCB1—Vincristine—kidney cancer	0.00151	0.00821	CbGbCtD
Gemcitabine—ABCB1—Sunitinib—kidney cancer	0.00126	0.00685	CbGbCtD
Gemcitabine—SLC28A1—nephron tubule—kidney cancer	0.00118	0.0622	CbGeAlD
Gemcitabine—Lamivudine—PGK1—kidney cancer	0.00118	0.955	CrCbGaD
Gemcitabine—SLC28A1—renal system—kidney cancer	0.00107	0.0565	CbGeAlD
Gemcitabine—SLC28A1—kidney—kidney cancer	0.00104	0.0547	CbGeAlD
Gemcitabine—SLC28A1—cortex of kidney—kidney cancer	0.00101	0.0532	CbGeAlD
Gemcitabine—ABCB1—Doxorubicin—kidney cancer	0.000946	0.00513	CbGbCtD
Gemcitabine—POLD1—renal system—kidney cancer	0.000715	0.0377	CbGeAlD
Gemcitabine—POLD1—gonad—kidney cancer	0.000642	0.0338	CbGeAlD
Gemcitabine—CMPK1—nephron tubule—kidney cancer	0.000628	0.0331	CbGeAlD
Gemcitabine—CMPK1—renal system—kidney cancer	0.000571	0.03	CbGeAlD
Gemcitabine—CMPK1—kidney—kidney cancer	0.000552	0.029	CbGeAlD
Gemcitabine—SLC29A2—cardiac atrium—kidney cancer	0.000537	0.0283	CbGeAlD
Gemcitabine—CMPK1—cortex of kidney—kidney cancer	0.000537	0.0283	CbGeAlD
Gemcitabine—CMPK1—gonad—kidney cancer	0.000512	0.0269	CbGeAlD
Gemcitabine—CMPK1—cardiac atrium—kidney cancer	0.000511	0.0269	CbGeAlD
Gemcitabine—POLE—cortex of kidney—kidney cancer	0.000504	0.0265	CbGeAlD
Gemcitabine—POLE—gonad—kidney cancer	0.00048	0.0252	CbGeAlD
Gemcitabine—RRM2—renal system—kidney cancer	0.00044	0.0232	CbGeAlD
Gemcitabine—RRM2—kidney—kidney cancer	0.000426	0.0224	CbGeAlD
Gemcitabine—RRM1—nephron tubule—kidney cancer	0.000403	0.0212	CbGeAlD
Gemcitabine—RRM2—gonad—kidney cancer	0.000395	0.0208	CbGeAlD
Gemcitabine—RRM1—renal system—kidney cancer	0.000366	0.0193	CbGeAlD
Gemcitabine—TYMS—nephron tubule—kidney cancer	0.000365	0.0192	CbGeAlD
Gemcitabine—RRM1—kidney—kidney cancer	0.000354	0.0186	CbGeAlD
Gemcitabine—RRM1—cortex of kidney—kidney cancer	0.000345	0.0181	CbGeAlD
Gemcitabine—RRM1—gonad—kidney cancer	0.000328	0.0173	CbGeAlD
Gemcitabine—RRM1—cardiac atrium—kidney cancer	0.000328	0.0172	CbGeAlD
Gemcitabine—DCK—nephron tubule—kidney cancer	0.000313	0.0165	CbGeAlD
Gemcitabine—TYMS—cortex of kidney—kidney cancer	0.000312	0.0164	CbGeAlD
Gemcitabine—SLC29A1—renal system—kidney cancer	0.000298	0.0157	CbGeAlD
Gemcitabine—TYMS—gonad—kidney cancer	0.000298	0.0157	CbGeAlD
Gemcitabine—SLC29A1—kidney—kidney cancer	0.000288	0.0151	CbGeAlD
Gemcitabine—SLC29A1—cortex of kidney—kidney cancer	0.00028	0.0147	CbGeAlD
Gemcitabine—ABCC10—renal system—kidney cancer	0.000271	0.0143	CbGeAlD
Gemcitabine—DCK—cortex of kidney—kidney cancer	0.000268	0.0141	CbGeAlD
Gemcitabine—SLC29A1—gonad—kidney cancer	0.000267	0.014	CbGeAlD
Gemcitabine—SLC29A1—cardiac atrium—kidney cancer	0.000266	0.014	CbGeAlD
Gemcitabine—ABCC10—kidney—kidney cancer	0.000262	0.0138	CbGeAlD
Gemcitabine—ABCC10—cortex of kidney—kidney cancer	0.000255	0.0134	CbGeAlD
Gemcitabine—DCK—gonad—kidney cancer	0.000255	0.0134	CbGeAlD
Gemcitabine—DCK—cardiac atrium—kidney cancer	0.000255	0.0134	CbGeAlD
Gemcitabine—ABCC10—gonad—kidney cancer	0.000243	0.0128	CbGeAlD
Gemcitabine—ABCC10—cardiac atrium—kidney cancer	0.000243	0.0128	CbGeAlD
Gemcitabine—RRM2—Gefitinib—Erlotinib—kidney cancer	0.000168	0.134	CbGdCrCtD
Gemcitabine—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.00015	0.119	CbGdCrCtD
Gemcitabine—RRM2—Vinorelbine—Vincristine—kidney cancer	0.000113	0.0895	CbGdCrCtD
Gemcitabine—RRM2—Vinorelbine—Vinblastine—kidney cancer	0.000113	0.0895	CbGdCrCtD
Gemcitabine—POLA1—Vinblastine—Vincristine—kidney cancer	0.000107	0.0847	CbGdCrCtD
Gemcitabine—DCK—Sirolimus—Temsirolimus—kidney cancer	9.57e-05	0.076	CbGdCrCtD
Gemcitabine—DCK—Sirolimus—Everolimus—kidney cancer	9.57e-05	0.076	CbGdCrCtD
Gemcitabine—ABCB1—nephron tubule—kidney cancer	8.6e-05	0.00453	CbGeAlD
Gemcitabine—ABCB1—renal system—kidney cancer	7.82e-05	0.00412	CbGeAlD
Gemcitabine—ABCB1—kidney—kidney cancer	7.56e-05	0.00398	CbGeAlD
Gemcitabine—ABCB1—cortex of kidney—kidney cancer	7.36e-05	0.00387	CbGeAlD
Gemcitabine—TYMS—Sirolimus—Everolimus—kidney cancer	7.2e-05	0.0572	CbGdCrCtD
Gemcitabine—TYMS—Sirolimus—Temsirolimus—kidney cancer	7.2e-05	0.0572	CbGdCrCtD
Gemcitabine—TYMS—Gefitinib—Erlotinib—kidney cancer	7.18e-05	0.0571	CbGdCrCtD
Gemcitabine—ABCB1—gonad—kidney cancer	7.01e-05	0.00369	CbGeAlD
Gemcitabine—Lamivudine—ABCB1—kidney cancer	5.59e-05	0.0453	CrCbGaD
Gemcitabine—TYMS—Vinorelbine—Vinblastine—kidney cancer	4.81e-05	0.0382	CbGdCrCtD
Gemcitabine—TYMS—Vinorelbine—Vincristine—kidney cancer	4.81e-05	0.0382	CbGdCrCtD
Gemcitabine—TYMS—Vincristine—Vinblastine—kidney cancer	4.11e-05	0.0327	CbGdCrCtD
Gemcitabine—TYMS—Vinblastine—Vincristine—kidney cancer	3.31e-05	0.0263	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—kidney cancer	3.08e-05	0.0245	CbGdCrCtD
Gemcitabine—Haematuria—Capecitabine—kidney cancer	2.49e-05	0.000392	CcSEcCtD
Gemcitabine—Erythema—Paclitaxel—kidney cancer	2.49e-05	0.000392	CcSEcCtD
Gemcitabine—Decreased appetite—Dactinomycin—kidney cancer	2.49e-05	0.000391	CcSEcCtD
Gemcitabine—Diarrhoea—Vinblastine—kidney cancer	2.49e-05	0.000391	CcSEcCtD
Gemcitabine—Body temperature increased—Sorafenib—kidney cancer	2.49e-05	0.000391	CcSEcCtD
Gemcitabine—Diarrhoea—Everolimus—kidney cancer	2.48e-05	0.00039	CcSEcCtD
Gemcitabine—Hyperhidrosis—Vincristine—kidney cancer	2.47e-05	0.000389	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Capecitabine—kidney cancer	2.47e-05	0.000389	CcSEcCtD
Gemcitabine—Pruritus—Erlotinib—kidney cancer	2.47e-05	0.000389	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—kidney cancer	2.47e-05	0.000388	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—kidney cancer	2.45e-05	0.000385	CcSEcCtD
Gemcitabine—Agranulocytosis—Capecitabine—kidney cancer	2.44e-05	0.000384	CcSEcCtD
Gemcitabine—Anorexia—Vincristine—kidney cancer	2.44e-05	0.000384	CcSEcCtD
Gemcitabine—Hepatic failure—Doxorubicin—kidney cancer	2.43e-05	0.000383	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Doxorubicin—kidney cancer	2.41e-05	0.000379	CcSEcCtD
Gemcitabine—Back pain—Paclitaxel—kidney cancer	2.41e-05	0.000379	CcSEcCtD
Gemcitabine—Body temperature increased—Sunitinib—kidney cancer	2.39e-05	0.000376	CcSEcCtD
Gemcitabine—Diarrhoea—Erlotinib—kidney cancer	2.39e-05	0.000376	CcSEcCtD
Gemcitabine—Hypotension—Vincristine—kidney cancer	2.39e-05	0.000376	CcSEcCtD
Gemcitabine—Feeling abnormal—Dactinomycin—kidney cancer	2.36e-05	0.000371	CcSEcCtD
Gemcitabine—Haemoglobin—Capecitabine—kidney cancer	2.36e-05	0.000371	CcSEcCtD
Gemcitabine—Rhinitis—Capecitabine—kidney cancer	2.35e-05	0.00037	CcSEcCtD
Gemcitabine—Haemorrhage—Capecitabine—kidney cancer	2.35e-05	0.000369	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Vincristine—kidney cancer	2.33e-05	0.000367	CcSEcCtD
Gemcitabine—Pharyngitis—Capecitabine—kidney cancer	2.33e-05	0.000366	CcSEcCtD
Gemcitabine—Urinary tract disorder—Capecitabine—kidney cancer	2.32e-05	0.000365	CcSEcCtD
Gemcitabine—Insomnia—Vincristine—kidney cancer	2.31e-05	0.000364	CcSEcCtD
Gemcitabine—Oedema peripheral—Capecitabine—kidney cancer	2.31e-05	0.000364	CcSEcCtD
Gemcitabine—Vomiting—Vinblastine—kidney cancer	2.31e-05	0.000363	CcSEcCtD
Gemcitabine—Ill-defined disorder—Paclitaxel—kidney cancer	2.31e-05	0.000363	CcSEcCtD
Gemcitabine—Connective tissue disorder—Capecitabine—kidney cancer	2.31e-05	0.000363	CcSEcCtD
Gemcitabine—Vomiting—Everolimus—kidney cancer	2.3e-05	0.000362	CcSEcCtD
Gemcitabine—Anaemia—Paclitaxel—kidney cancer	2.3e-05	0.000362	CcSEcCtD
Gemcitabine—Urethral disorder—Capecitabine—kidney cancer	2.3e-05	0.000362	CcSEcCtD
Gemcitabine—Renal impairment—Doxorubicin—kidney cancer	2.3e-05	0.000361	CcSEcCtD
Gemcitabine—Paraesthesia—Vincristine—kidney cancer	2.3e-05	0.000361	CcSEcCtD
Gemcitabine—Dermatitis bullous—Doxorubicin—kidney cancer	2.29e-05	0.00036	CcSEcCtD
Gemcitabine—Rash—Everolimus—kidney cancer	2.28e-05	0.000359	CcSEcCtD
Gemcitabine—Dermatitis—Everolimus—kidney cancer	2.28e-05	0.000359	CcSEcCtD
Gemcitabine—Headache—Vinblastine—kidney cancer	2.28e-05	0.000358	CcSEcCtD
Gemcitabine—Headache—Everolimus—kidney cancer	2.27e-05	0.000357	CcSEcCtD
Gemcitabine—Body temperature increased—Dactinomycin—kidney cancer	2.26e-05	0.000356	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—kidney cancer	2.26e-05	0.000355	CcSEcCtD
Gemcitabine—Asthenia—Sorafenib—kidney cancer	2.26e-05	0.000355	CcSEcCtD
Gemcitabine—Malaise—Paclitaxel—kidney cancer	2.25e-05	0.000353	CcSEcCtD
Gemcitabine—Cardiac failure—Doxorubicin—kidney cancer	2.24e-05	0.000352	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Doxorubicin—kidney cancer	2.23e-05	0.000351	CcSEcCtD
Gemcitabine—Leukopenia—Paclitaxel—kidney cancer	2.23e-05	0.00035	CcSEcCtD
Gemcitabine—Decreased appetite—Vincristine—kidney cancer	2.22e-05	0.00035	CcSEcCtD
Gemcitabine—Pruritus—Sorafenib—kidney cancer	2.22e-05	0.00035	CcSEcCtD
Gemcitabine—Vomiting—Erlotinib—kidney cancer	2.22e-05	0.000349	CcSEcCtD
Gemcitabine—Erythema multiforme—Capecitabine—kidney cancer	2.22e-05	0.000349	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Vincristine—kidney cancer	2.21e-05	0.000347	CcSEcCtD
Gemcitabine—Fatigue—Vincristine—kidney cancer	2.21e-05	0.000347	CcSEcCtD
Gemcitabine—Rash—Erlotinib—kidney cancer	2.2e-05	0.000346	CcSEcCtD
Gemcitabine—Dermatitis—Erlotinib—kidney cancer	2.2e-05	0.000346	CcSEcCtD
Gemcitabine—Headache—Erlotinib—kidney cancer	2.19e-05	0.000344	CcSEcCtD
Gemcitabine—Pain—Vincristine—kidney cancer	2.19e-05	0.000344	CcSEcCtD
Gemcitabine—Constipation—Vincristine—kidney cancer	2.19e-05	0.000344	CcSEcCtD
Gemcitabine—Cardiac disorder—Capecitabine—kidney cancer	2.18e-05	0.000343	CcSEcCtD
Gemcitabine—Cough—Paclitaxel—kidney cancer	2.17e-05	0.000342	CcSEcCtD
Gemcitabine—Asthenia—Sunitinib—kidney cancer	2.17e-05	0.000341	CcSEcCtD
Gemcitabine—Nausea—Vinblastine—kidney cancer	2.16e-05	0.00034	CcSEcCtD
Gemcitabine—Nausea—Everolimus—kidney cancer	2.15e-05	0.000338	CcSEcCtD
Gemcitabine—Diarrhoea—Sorafenib—kidney cancer	2.15e-05	0.000338	CcSEcCtD
Gemcitabine—Hypertension—Paclitaxel—kidney cancer	2.15e-05	0.000338	CcSEcCtD
Gemcitabine—Pruritus—Sunitinib—kidney cancer	2.14e-05	0.000337	CcSEcCtD
Gemcitabine—Angiopathy—Capecitabine—kidney cancer	2.13e-05	0.000335	CcSEcCtD
Gemcitabine—Immune system disorder—Capecitabine—kidney cancer	2.12e-05	0.000333	CcSEcCtD
Gemcitabine—Chest pain—Paclitaxel—kidney cancer	2.12e-05	0.000333	CcSEcCtD
Gemcitabine—Arthralgia—Paclitaxel—kidney cancer	2.12e-05	0.000333	CcSEcCtD
Gemcitabine—Myalgia—Paclitaxel—kidney cancer	2.12e-05	0.000333	CcSEcCtD
Gemcitabine—Mediastinal disorder—Capecitabine—kidney cancer	2.12e-05	0.000333	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—kidney cancer	2.11e-05	0.000332	CcSEcCtD
Gemcitabine—Chills—Capecitabine—kidney cancer	2.11e-05	0.000331	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.11e-05	0.000331	CcSEcCtD
Gemcitabine—Arrhythmia—Capecitabine—kidney cancer	2.1e-05	0.00033	CcSEcCtD
Gemcitabine—Discomfort—Paclitaxel—kidney cancer	2.09e-05	0.000329	CcSEcCtD
Gemcitabine—Nausea—Erlotinib—kidney cancer	2.08e-05	0.000326	CcSEcCtD
Gemcitabine—Alopecia—Capecitabine—kidney cancer	2.07e-05	0.000326	CcSEcCtD
Gemcitabine—Diarrhoea—Sunitinib—kidney cancer	2.07e-05	0.000325	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—kidney cancer	2.05e-05	0.000323	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—kidney cancer	2.05e-05	0.000322	CcSEcCtD
Gemcitabine—Erythema—Capecitabine—kidney cancer	2.04e-05	0.000321	CcSEcCtD
Gemcitabine—Oedema—Paclitaxel—kidney cancer	2.03e-05	0.00032	CcSEcCtD
Gemcitabine—Anaphylactic shock—Paclitaxel—kidney cancer	2.03e-05	0.00032	CcSEcCtD
Gemcitabine—Body temperature increased—Vincristine—kidney cancer	2.02e-05	0.000318	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—kidney cancer	2.02e-05	0.000318	CcSEcCtD
Gemcitabine—Infection—Paclitaxel—kidney cancer	2.02e-05	0.000317	CcSEcCtD
Gemcitabine—Vomiting—Sorafenib—kidney cancer	2e-05	0.000314	CcSEcCtD
Gemcitabine—Nervous system disorder—Paclitaxel—kidney cancer	1.99e-05	0.000313	CcSEcCtD
Gemcitabine—Hypokalaemia—Doxorubicin—kidney cancer	1.99e-05	0.000313	CcSEcCtD
Gemcitabine—Thrombocytopenia—Paclitaxel—kidney cancer	1.99e-05	0.000313	CcSEcCtD
Gemcitabine—Rash—Sorafenib—kidney cancer	1.98e-05	0.000312	CcSEcCtD
Gemcitabine—Dermatitis—Sorafenib—kidney cancer	1.98e-05	0.000311	CcSEcCtD
Gemcitabine—Back pain—Capecitabine—kidney cancer	1.98e-05	0.000311	CcSEcCtD
Gemcitabine—Skin disorder—Paclitaxel—kidney cancer	1.97e-05	0.00031	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	1.97e-05	0.00031	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.97e-05	0.00031	CcSEcCtD
Gemcitabine—Headache—Sorafenib—kidney cancer	1.97e-05	0.00031	CcSEcCtD
Gemcitabine—Hyperhidrosis—Paclitaxel—kidney cancer	1.96e-05	0.000309	CcSEcCtD
Gemcitabine—Diarrhoea—Dactinomycin—kidney cancer	1.96e-05	0.000308	CcSEcCtD
Gemcitabine—Anorexia—Paclitaxel—kidney cancer	1.94e-05	0.000305	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	1.93e-05	0.000303	CcSEcCtD
Gemcitabine—Vomiting—Sunitinib—kidney cancer	1.92e-05	0.000302	CcSEcCtD
Gemcitabine—Rash—Sunitinib—kidney cancer	1.91e-05	0.0003	CcSEcCtD
Gemcitabine—Dermatitis—Sunitinib—kidney cancer	1.91e-05	0.0003	CcSEcCtD
Gemcitabine—Hypotension—Paclitaxel—kidney cancer	1.9e-05	0.000299	CcSEcCtD
Gemcitabine—Ill-defined disorder—Capecitabine—kidney cancer	1.9e-05	0.000298	CcSEcCtD
Gemcitabine—Headache—Sunitinib—kidney cancer	1.89e-05	0.000298	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—kidney cancer	1.89e-05	0.000297	CcSEcCtD
Gemcitabine—Anaemia—Capecitabine—kidney cancer	1.89e-05	0.000297	CcSEcCtD
Gemcitabine—Nausea—Sorafenib—kidney cancer	1.87e-05	0.000294	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.85e-05	0.000291	CcSEcCtD
Gemcitabine—Malaise—Capecitabine—kidney cancer	1.84e-05	0.00029	CcSEcCtD
Gemcitabine—Insomnia—Paclitaxel—kidney cancer	1.84e-05	0.000289	CcSEcCtD
Gemcitabine—Asthenia—Vincristine—kidney cancer	1.84e-05	0.000289	CcSEcCtD
Gemcitabine—Leukopenia—Capecitabine—kidney cancer	1.83e-05	0.000288	CcSEcCtD
Gemcitabine—Paraesthesia—Paclitaxel—kidney cancer	1.82e-05	0.000287	CcSEcCtD
Gemcitabine—Vomiting—Dactinomycin—kidney cancer	1.82e-05	0.000286	CcSEcCtD
Gemcitabine—Dyspnoea—Paclitaxel—kidney cancer	1.81e-05	0.000285	CcSEcCtD
Gemcitabine—Somnolence—Paclitaxel—kidney cancer	1.81e-05	0.000284	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—kidney cancer	1.81e-05	0.000284	CcSEcCtD
Gemcitabine—Nausea—Sunitinib—kidney cancer	1.8e-05	0.000283	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—kidney cancer	1.8e-05	0.000282	CcSEcCtD
Gemcitabine—Cough—Capecitabine—kidney cancer	1.78e-05	0.00028	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—kidney cancer	1.77e-05	0.000278	CcSEcCtD
Gemcitabine—Decreased appetite—Paclitaxel—kidney cancer	1.77e-05	0.000278	CcSEcCtD
Gemcitabine—Hypertension—Capecitabine—kidney cancer	1.76e-05	0.000277	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.75e-05	0.000276	CcSEcCtD
Gemcitabine—Fatigue—Paclitaxel—kidney cancer	1.75e-05	0.000276	CcSEcCtD
Gemcitabine—Diarrhoea—Vincristine—kidney cancer	1.75e-05	0.000275	CcSEcCtD
Gemcitabine—Chest pain—Capecitabine—kidney cancer	1.74e-05	0.000274	CcSEcCtD
Gemcitabine—Myalgia—Capecitabine—kidney cancer	1.74e-05	0.000274	CcSEcCtD
Gemcitabine—Arthralgia—Capecitabine—kidney cancer	1.74e-05	0.000274	CcSEcCtD
Gemcitabine—Constipation—Paclitaxel—kidney cancer	1.74e-05	0.000273	CcSEcCtD
Gemcitabine—Pain—Paclitaxel—kidney cancer	1.74e-05	0.000273	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.73e-05	0.000272	CcSEcCtD
Gemcitabine—Discomfort—Capecitabine—kidney cancer	1.72e-05	0.00027	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—kidney cancer	1.71e-05	0.000268	CcSEcCtD
Gemcitabine—Nausea—Dactinomycin—kidney cancer	1.7e-05	0.000267	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—kidney cancer	1.7e-05	0.000267	CcSEcCtD
Gemcitabine—Feeling abnormal—Paclitaxel—kidney cancer	1.67e-05	0.000263	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.67e-05	0.000263	CcSEcCtD
Gemcitabine—Oedema—Capecitabine—kidney cancer	1.67e-05	0.000262	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—kidney cancer	1.66e-05	0.000261	CcSEcCtD
Gemcitabine—Infection—Capecitabine—kidney cancer	1.66e-05	0.000261	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.65e-05	0.00026	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—kidney cancer	1.64e-05	0.000258	CcSEcCtD
Gemcitabine—Nervous system disorder—Capecitabine—kidney cancer	1.64e-05	0.000257	CcSEcCtD
Gemcitabine—Thrombocytopenia—Capecitabine—kidney cancer	1.63e-05	0.000257	CcSEcCtD
Gemcitabine—Vomiting—Vincristine—kidney cancer	1.63e-05	0.000256	CcSEcCtD
Gemcitabine—Skin disorder—Capecitabine—kidney cancer	1.62e-05	0.000255	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—kidney cancer	1.62e-05	0.000254	CcSEcCtD
Gemcitabine—Rash—Vincristine—kidney cancer	1.61e-05	0.000254	CcSEcCtD
Gemcitabine—Hyperhidrosis—Capecitabine—kidney cancer	1.61e-05	0.000254	CcSEcCtD
Gemcitabine—Dermatitis—Vincristine—kidney cancer	1.61e-05	0.000253	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—kidney cancer	1.61e-05	0.000253	CcSEcCtD
Gemcitabine—Body temperature increased—Paclitaxel—kidney cancer	1.61e-05	0.000253	CcSEcCtD
Gemcitabine—Headache—Vincristine—kidney cancer	1.6e-05	0.000252	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—kidney cancer	1.59e-05	0.000251	CcSEcCtD
Gemcitabine—Anorexia—Capecitabine—kidney cancer	1.59e-05	0.00025	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—kidney cancer	1.57e-05	0.000247	CcSEcCtD
Gemcitabine—Hypotension—Capecitabine—kidney cancer	1.56e-05	0.000245	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—kidney cancer	1.52e-05	0.000239	CcSEcCtD
Gemcitabine—Nausea—Vincristine—kidney cancer	1.52e-05	0.000239	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.52e-05	0.000239	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—kidney cancer	1.52e-05	0.000239	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—kidney cancer	1.51e-05	0.000238	CcSEcCtD
Gemcitabine—Insomnia—Capecitabine—kidney cancer	1.51e-05	0.000237	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—kidney cancer	1.5e-05	0.000236	CcSEcCtD
Gemcitabine—Paraesthesia—Capecitabine—kidney cancer	1.5e-05	0.000235	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—kidney cancer	1.49e-05	0.000235	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—kidney cancer	1.49e-05	0.000234	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—kidney cancer	1.49e-05	0.000234	CcSEcCtD
Gemcitabine—Dyspnoea—Capecitabine—kidney cancer	1.49e-05	0.000234	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—kidney cancer	1.48e-05	0.000233	CcSEcCtD
Gemcitabine—Asthenia—Paclitaxel—kidney cancer	1.46e-05	0.000229	CcSEcCtD
Gemcitabine—Decreased appetite—Capecitabine—kidney cancer	1.45e-05	0.000228	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Capecitabine—kidney cancer	1.44e-05	0.000226	CcSEcCtD
Gemcitabine—Fatigue—Capecitabine—kidney cancer	1.44e-05	0.000226	CcSEcCtD
Gemcitabine—Pruritus—Paclitaxel—kidney cancer	1.44e-05	0.000226	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—kidney cancer	1.43e-05	0.000225	CcSEcCtD
Gemcitabine—Constipation—Capecitabine—kidney cancer	1.43e-05	0.000224	CcSEcCtD
Gemcitabine—Pain—Capecitabine—kidney cancer	1.43e-05	0.000224	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—kidney cancer	1.4e-05	0.000221	CcSEcCtD
Gemcitabine—Diarrhoea—Paclitaxel—kidney cancer	1.39e-05	0.000219	CcSEcCtD
Gemcitabine—Feeling abnormal—Capecitabine—kidney cancer	1.37e-05	0.000216	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—kidney cancer	1.37e-05	0.000216	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—kidney cancer	1.37e-05	0.000215	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—kidney cancer	1.36e-05	0.000214	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—kidney cancer	1.36e-05	0.000213	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—kidney cancer	1.35e-05	0.000213	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—kidney cancer	1.34e-05	0.00021	CcSEcCtD
Gemcitabine—Body temperature increased—Capecitabine—kidney cancer	1.32e-05	0.000207	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—kidney cancer	1.32e-05	0.000207	CcSEcCtD
Gemcitabine—Vomiting—Paclitaxel—kidney cancer	1.29e-05	0.000203	CcSEcCtD
Gemcitabine—Rash—Paclitaxel—kidney cancer	1.28e-05	0.000201	CcSEcCtD
Gemcitabine—Dermatitis—Paclitaxel—kidney cancer	1.28e-05	0.000201	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—kidney cancer	1.27e-05	0.0002	CcSEcCtD
Gemcitabine—Headache—Paclitaxel—kidney cancer	1.27e-05	0.0002	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—kidney cancer	1.22e-05	0.000192	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—kidney cancer	1.22e-05	0.000191	CcSEcCtD
Gemcitabine—Nausea—Paclitaxel—kidney cancer	1.21e-05	0.00019	CcSEcCtD
Gemcitabine—Asthenia—Capecitabine—kidney cancer	1.2e-05	0.000188	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—kidney cancer	1.19e-05	0.000187	CcSEcCtD
Gemcitabine—Pruritus—Capecitabine—kidney cancer	1.18e-05	0.000186	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—kidney cancer	1.18e-05	0.000185	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—kidney cancer	1.15e-05	0.000181	CcSEcCtD
Gemcitabine—Diarrhoea—Capecitabine—kidney cancer	1.14e-05	0.000179	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—kidney cancer	1.14e-05	0.000179	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—kidney cancer	1.12e-05	0.000176	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—kidney cancer	1.12e-05	0.000176	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—kidney cancer	1.12e-05	0.000176	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.11e-05	0.000175	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—kidney cancer	1.11e-05	0.000174	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—kidney cancer	1.07e-05	0.000169	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—kidney cancer	1.07e-05	0.000169	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—kidney cancer	1.07e-05	0.000168	CcSEcCtD
Gemcitabine—Vomiting—Capecitabine—kidney cancer	1.06e-05	0.000167	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—kidney cancer	1.05e-05	0.000166	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—kidney cancer	1.05e-05	0.000166	CcSEcCtD
Gemcitabine—Rash—Capecitabine—kidney cancer	1.05e-05	0.000165	CcSEcCtD
Gemcitabine—Dermatitis—Capecitabine—kidney cancer	1.05e-05	0.000165	CcSEcCtD
Gemcitabine—Headache—Capecitabine—kidney cancer	1.04e-05	0.000164	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—kidney cancer	1.04e-05	0.000164	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—kidney cancer	1.04e-05	0.000163	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—kidney cancer	1.02e-05	0.000161	CcSEcCtD
Gemcitabine—TYMS—Metabolism—SLC5A3—kidney cancer	1.02e-05	0.000379	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PGK1—kidney cancer	1.02e-05	0.000379	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—kidney cancer	1.01e-05	0.000375	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—BCHE—kidney cancer	1.01e-05	0.000375	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCB1—kidney cancer	1e-05	0.000372	CbGpPWpGaD
Gemcitabine—Hypotension—Doxorubicin—kidney cancer	1e-05	0.000158	CcSEcCtD
Gemcitabine—TYMS—Metabolism—LDHB—kidney cancer	1e-05	0.000371	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SLC5A5—kidney cancer	9.98e-06	0.00037	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.94e-06	0.000368	CbGpPWpGaD
Gemcitabine—Nausea—Capecitabine—kidney cancer	9.91e-06	0.000156	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—BRCA2—kidney cancer	9.87e-06	0.000366	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BIRC5—kidney cancer	9.86e-06	0.000365	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.79e-06	0.000154	CcSEcCtD
Gemcitabine—DCK—Metabolism—ITPR2—kidney cancer	9.79e-06	0.000363	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2B—kidney cancer	9.79e-06	0.000363	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTM1—kidney cancer	9.75e-06	0.000361	CbGpPWpGaD
Gemcitabine—Insomnia—Doxorubicin—kidney cancer	9.72e-06	0.000153	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—kidney cancer	9.65e-06	0.000152	CcSEcCtD
Gemcitabine—RRM1—Metabolism—SLC2A1—kidney cancer	9.64e-06	0.000357	CbGpPWpGaD
Gemcitabine—Dyspnoea—Doxorubicin—kidney cancer	9.58e-06	0.000151	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—kidney cancer	9.56e-06	0.00015	CcSEcCtD
Gemcitabine—RRM2—Metabolism—GSTT1—kidney cancer	9.55e-06	0.000354	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ACHE—kidney cancer	9.55e-06	0.000354	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—kidney cancer	9.55e-06	0.000354	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	9.55e-06	0.000354	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.52e-06	0.000353	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—kidney cancer	9.5e-06	0.000352	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ACHE—kidney cancer	9.5e-06	0.000352	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—kidney cancer	9.49e-06	0.000352	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	9.45e-06	0.00035	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	9.4e-06	0.000349	CbGpPWpGaD
Gemcitabine—Decreased appetite—Doxorubicin—kidney cancer	9.34e-06	0.000147	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.28e-06	0.000146	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—kidney cancer	9.27e-06	0.000146	CcSEcCtD
Gemcitabine—CDA—Metabolism—CYP1A1—kidney cancer	9.24e-06	0.000343	CbGpPWpGaD
Gemcitabine—Pain—Doxorubicin—kidney cancer	9.19e-06	0.000145	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—kidney cancer	9.19e-06	0.000145	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—kidney cancer	9.17e-06	0.00034	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	9.15e-06	0.000339	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SCARB1—kidney cancer	9.04e-06	0.000335	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	9.01e-06	0.000334	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SCARB1—kidney cancer	8.99e-06	0.000333	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS1—kidney cancer	8.95e-06	0.000332	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.95e-06	0.000332	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—kidney cancer	8.93e-06	0.000331	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ACHE—kidney cancer	8.93e-06	0.000331	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS1—kidney cancer	8.9e-06	0.00033	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—kidney cancer	8.9e-06	0.00033	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—kidney cancer	8.86e-06	0.000139	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—BIRC5—kidney cancer	8.82e-06	0.000327	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PSMD7—kidney cancer	8.78e-06	0.000325	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.76e-06	0.000325	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PSMD7—kidney cancer	8.73e-06	0.000323	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CA9—kidney cancer	8.69e-06	0.000322	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.57e-06	0.000318	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	8.57e-06	0.000318	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	8.57e-06	0.000318	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK3—kidney cancer	8.54e-06	0.000317	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—kidney cancer	8.54e-06	0.000317	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—kidney cancer	8.5e-06	0.000134	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—kidney cancer	8.49e-06	0.000315	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—kidney cancer	8.46e-06	0.000314	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SCARB1—kidney cancer	8.45e-06	0.000313	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.45e-06	0.000313	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BIRC5—kidney cancer	8.45e-06	0.000313	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.41e-06	0.000312	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—kidney cancer	8.41e-06	0.000312	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS1—kidney cancer	8.37e-06	0.00031	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—BCHE—kidney cancer	8.32e-06	0.000309	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—BCHE—kidney cancer	8.27e-06	0.000307	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC5A5—kidney cancer	8.22e-06	0.000305	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSMD7—kidney cancer	8.21e-06	0.000304	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—kidney cancer	8.2e-06	0.000304	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC5A5—kidney cancer	8.17e-06	0.000303	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK1—kidney cancer	8.13e-06	0.000301	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—kidney cancer	8.12e-06	0.000301	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.1e-06	0.0003	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—kidney cancer	8.07e-06	0.000299	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—kidney cancer	8.04e-06	0.000298	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	8.03e-06	0.000298	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—kidney cancer	8.02e-06	0.000297	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	8.02e-06	0.000297	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC2A1—kidney cancer	7.94e-06	0.000294	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC2A1—kidney cancer	7.89e-06	0.000293	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	7.87e-06	0.000292	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—BCHE—kidney cancer	7.78e-06	0.000288	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.76e-06	0.000288	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—kidney cancer	7.76e-06	0.000288	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—kidney cancer	7.75e-06	0.000287	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—kidney cancer	7.71e-06	0.000121	CcSEcCtD
Gemcitabine—DCK—Metabolism—SLC5A5—kidney cancer	7.68e-06	0.000285	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—kidney cancer	7.61e-06	0.000282	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—kidney cancer	7.61e-06	0.00012	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—kidney cancer	7.56e-06	0.00028	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—kidney cancer	7.52e-06	0.000279	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.51e-06	0.000278	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.44e-06	0.000276	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC2A1—kidney cancer	7.42e-06	0.000275	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—kidney cancer	7.39e-06	0.000274	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CRABP1—kidney cancer	7.39e-06	0.000274	CbGpPWpGaD
Gemcitabine—Diarrhoea—Doxorubicin—kidney cancer	7.35e-06	0.000116	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—CDKN1B—kidney cancer	7.26e-06	0.000269	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—kidney cancer	7.22e-06	0.000267	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.2e-06	0.000267	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—kidney cancer	7.17e-06	0.000266	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	7.04e-06	0.000261	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—kidney cancer	7.01e-06	0.00026	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1A1—kidney cancer	7.01e-06	0.00026	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	6.98e-06	0.000259	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—kidney cancer	6.93e-06	0.000257	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—kidney cancer	6.91e-06	0.000256	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—POMC—kidney cancer	6.89e-06	0.000256	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	6.88e-06	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ITPR2—kidney cancer	6.87e-06	0.000255	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—kidney cancer	6.83e-06	0.000107	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—kidney cancer	6.78e-06	0.000107	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—kidney cancer	6.77e-06	0.000106	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—kidney cancer	6.73e-06	0.000106	CcSEcCtD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.73e-06	0.000249	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.73e-06	0.000249	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.73e-06	0.000249	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK3—kidney cancer	6.66e-06	0.000247	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—kidney cancer	6.62e-06	0.000245	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK3—kidney cancer	6.62e-06	0.000245	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—kidney cancer	6.58e-06	0.000244	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.53e-06	0.000242	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—kidney cancer	6.47e-06	0.00024	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—kidney cancer	6.43e-06	0.000238	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK3—kidney cancer	6.39e-06	0.000237	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—kidney cancer	6.39e-06	0.0001	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK1—kidney cancer	6.33e-06	0.000235	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK1—kidney cancer	6.29e-06	0.000233	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—kidney cancer	6.27e-06	0.000232	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ACHE—kidney cancer	6.26e-06	0.000232	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—kidney cancer	6.26e-06	0.000232	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.26e-06	0.000232	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—kidney cancer	6.23e-06	0.000231	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—kidney cancer	6.21e-06	0.00023	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—kidney cancer	6.19e-06	0.000229	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK3—kidney cancer	6.09e-06	0.000226	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—kidney cancer	6.09e-06	0.000226	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK1—kidney cancer	6.08e-06	0.000225	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—kidney cancer	6.05e-06	0.000224	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACY1—kidney cancer	6e-06	0.000222	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—kidney cancer	5.95e-06	0.000221	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK3—kidney cancer	5.95e-06	0.000221	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SCARB1—kidney cancer	5.93e-06	0.00022	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK3—kidney cancer	5.91e-06	0.000219	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS1—kidney cancer	5.87e-06	0.000217	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—kidney cancer	5.86e-06	0.000217	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—kidney cancer	5.84e-06	0.000217	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK1—kidney cancer	5.79e-06	0.000215	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—kidney cancer	5.79e-06	0.000215	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.79e-06	0.000214	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1A1—kidney cancer	5.77e-06	0.000214	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMD7—kidney cancer	5.75e-06	0.000213	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—kidney cancer	5.75e-06	0.000213	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1A1—kidney cancer	5.73e-06	0.000213	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK3—kidney cancer	5.71e-06	0.000212	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—kidney cancer	5.69e-06	0.000211	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK1—kidney cancer	5.66e-06	0.00021	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK1—kidney cancer	5.63e-06	0.000209	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—kidney cancer	5.6e-06	0.000207	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—kidney cancer	5.56e-06	0.000206	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.54e-06	0.000205	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—kidney cancer	5.52e-06	0.000205	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—kidney cancer	5.5e-06	0.000204	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—kidney cancer	5.48e-06	0.000203	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BCHE—kidney cancer	5.45e-06	0.000202	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK1—kidney cancer	5.44e-06	0.000201	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A1—kidney cancer	5.39e-06	0.0002	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—kidney cancer	5.39e-06	0.0002	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	5.29e-06	0.000196	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—POMC—kidney cancer	5.22e-06	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC2A1—kidney cancer	5.2e-06	0.000193	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—kidney cancer	5.17e-06	0.000192	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PDHB—kidney cancer	5.1e-06	0.000189	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—kidney cancer	4.96e-06	0.000184	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—kidney cancer	4.94e-06	0.000183	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.91e-06	0.000182	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CCBL1—kidney cancer	4.8e-06	0.000178	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—kidney cancer	4.79e-06	0.000178	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—kidney cancer	4.75e-06	0.000176	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—kidney cancer	4.73e-06	0.000175	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—kidney cancer	4.72e-06	0.000175	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—kidney cancer	4.56e-06	0.000169	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.55e-06	0.000169	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—kidney cancer	4.43e-06	0.000164	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.36e-06	0.000162	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—kidney cancer	4.34e-06	0.000161	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.33e-06	0.000161	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—POMC—kidney cancer	4.3e-06	0.000159	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—POMC—kidney cancer	4.28e-06	0.000158	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	4.24e-06	0.000157	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—kidney cancer	4.17e-06	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPAT—kidney cancer	4.16e-06	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GLIPR1—kidney cancer	4.16e-06	0.000154	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.15e-06	0.000154	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—kidney cancer	4.11e-06	0.000152	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK3—kidney cancer	4.07e-06	0.000151	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—POMC—kidney cancer	4.02e-06	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—kidney cancer	3.99e-06	0.000148	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—kidney cancer	3.96e-06	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK3—kidney cancer	3.9e-06	0.000145	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK1—kidney cancer	3.87e-06	0.000144	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FH—kidney cancer	3.87e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APRT—kidney cancer	3.87e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.86e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.82e-06	0.000141	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—kidney cancer	3.79e-06	0.000141	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A1—kidney cancer	3.78e-06	0.00014	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.73e-06	0.000138	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK1—kidney cancer	3.71e-06	0.000138	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPC3—kidney cancer	3.64e-06	0.000135	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—kidney cancer	3.63e-06	0.000135	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.55e-06	0.000132	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA2—kidney cancer	3.54e-06	0.000131	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.53e-06	0.000131	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALAD—kidney cancer	3.45e-06	0.000128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—kidney cancer	3.43e-06	0.000127	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.43e-06	0.000127	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—kidney cancer	3.41e-06	0.000126	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—kidney cancer	3.38e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.37e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ST3GAL2—kidney cancer	3.36e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.36e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.34e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDH1A1—kidney cancer	3.29e-06	0.000122	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.25e-06	0.000121	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—kidney cancer	3.25e-06	0.000121	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—kidney cancer	3.21e-06	0.000119	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PGK1—kidney cancer	3.15e-06	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A3—kidney cancer	3.15e-06	0.000117	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—kidney cancer	3.11e-06	0.000115	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LDHB—kidney cancer	3.09e-06	0.000115	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—kidney cancer	2.99e-06	0.000111	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—kidney cancer	2.97e-06	0.00011	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.94e-06	0.000109	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—POMC—kidney cancer	2.82e-06	0.000104	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—kidney cancer	2.8e-06	0.000104	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.78e-06	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.7e-06	0.0001	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA9—kidney cancer	2.68e-06	9.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.64e-06	9.8e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—kidney cancer	2.56e-06	9.5e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.5e-06	9.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.3e-06	8.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CRABP1—kidney cancer	2.28e-06	8.45e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—kidney cancer	2.25e-06	8.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.22e-06	8.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ITPR2—kidney cancer	2.12e-06	7.85e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—kidney cancer	2.11e-06	7.82e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—kidney cancer	2.1e-06	7.78e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—kidney cancer	1.97e-06	7.31e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—kidney cancer	1.96e-06	7.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—kidney cancer	1.93e-06	7.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACHE—kidney cancer	1.93e-06	7.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SCARB1—kidney cancer	1.83e-06	6.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS1—kidney cancer	1.81e-06	6.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMD7—kidney cancer	1.78e-06	6.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BCHE—kidney cancer	1.68e-06	6.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—kidney cancer	1.66e-06	6.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A1—kidney cancer	1.61e-06	5.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.53e-06	5.68e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—kidney cancer	1.38e-06	5.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—kidney cancer	1.34e-06	4.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—kidney cancer	1.23e-06	4.56e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A1—kidney cancer	1.17e-06	4.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—POMC—kidney cancer	8.7e-07	3.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—kidney cancer	6.94e-07	2.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—kidney cancer	6.05e-07	2.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—kidney cancer	4.27e-07	1.58e-05	CbGpPWpGaD
